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Thirty-day mortality statistics underestimate
the risk of repair of thoracoabdominal aortic
aneurysms: A statewide experience
David A. Rigberg, MD, Marcia L. McGory, MD, David S. Zingmond, MD, PhD,
Melinda A. Maggard, MD, MSHS, Michelle Agustin, MPH, Peter F. Lawrence, MD, and
Clifford Y. Ko, MD, MS, MSHS, Los Angeles, Calif
Objective: The purpose of this study was to determine the 30-day and 365-day mortality for the repair of thoracoabdomi-
nal aortic aneurysms (TAA), when stratified by age, in the general population. These data provide clinicians with
information more applicable to an individual patient than mortality figures from a single institutional series.
Methods:Data were obtained from the California Office of StatewideHealth Planning andDevelopment (OSHPD) for the
years 1991 to 2002. These data were linked to the state death certificate file, allowing for continued information on the
status of the patients after hospital discharge. All patients undergoing elective and ruptured TAA repair as coded by
International Classification of Diseases, 9th Clinical Modification (ICD-9, CM) in California were identified. Patients
aged<50 or>90 years old were excluded.We determined 30- and 365-daymortality and stratified our findings by decade
of patient age (eg, 50 to 59). Demographics of elective and ruptured cases were also compared.
Results: We identified 1010 patients (797 elective, 213 ruptured) who underwent TAA repair. Mean patient ages were
70.0 (elective) and 72.1 years (ruptured). Men comprised 62% of elective and 68% of ruptured aneurysm patients, and
80% (elective) and 74% (ruptured) were white. Overall elective patient mortality was 19% at 30 days and 31% at 365 days.
There was a steep increase in mortality with increasing age, such that elective 365-day mortality increased from about 18%
for patients 50 to 59 years old to 40% for patients 80 to 89 years old. The elective case 31-day to 365-daymortality ranged
from 7.8% for the youngest patients to 13.5%. Mortality for ruptured cases was 48.4% at 30 days and 61.5% at 365 days,
and these rates also increased with age.
Conclusions: Our observed 30-day mortality for TAA repairs is consistent with previous reports; however, mortality at 1
year demonstrates a significant risk beyond the initial perioperative period, and this risk increases with age. These data
reflect surgical mortality for TAA repair in the general population and may provide more useful data for surgeons and
patients contemplating TAA surgery. (J Vasc Surg 2006;43:217-23.)The surgical repair of thoracoabdominal aneurysms
(TAAs) is one of the most technically demanding and
complex procedures performed by vascular surgeons. Al-
though the natural history of TAAs left untreated has not
been thoroughly elucidated, most authorities advise repair
of these lesions if patients have a life expectancy 2 years
and do not have comorbidities that prohibit operation.1
Reported outcomes for the repair of ruptured TAAs are
consistently and significantly worse than those after a
planned operation, so great efforts have been made to
repair intact lesions safely and effectively in an elective
manner.2
Most literature regarding the treatment of TAAs comes
from single institutional retrospective reviews, and these
studies have shown perioperative and 30-day mortalities of
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doi:10.1016/j.jvs.2005.10.0705.5% to 13%.3,4 As with other surgical procedures, out-
comes are usually worse when viewed in the general popu-
lation; two such studies show 21% in-hospital mortality
for TAA repair.5,6 No data regarding longer-term out-
comes in unselected populations are available, however.
Because TAA repair is undertaken to prolong life, survival
at 1 year may provide a more meaningful measure of
outcome. Some single institutional series have long-term
follow-up of TAA patients, but there are no data regarding
late mortality for this procedure in the general population.
An additional factor in assessing postoperative mortal-
ity is the role of advancing age. This is particularly critical in
vascular surgery, where the elderly comprise most of the
patient population. Data regarding the impact of age on
TAA repair outcomes are limited and mixed and comes
from single institutional reviews. We hypothesized that
there is continued and significantmortality after TAA repair
for the duration of the postoperative year and that this
mortality increases with advancing age.
METHODS
Data source. Discharge data for the years 1991 to
2002 were obtained from the California Office of Statewide
Health Planning and Development (OSHPD). The annual
OSHPD Patient Discharge Database (PDD) includes hos-
pitalization discharge abstracts from all licensed nonfederal
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cludes patient demographics, hospital identification code,
dates of admission and discharge, and codes for up to 20
inpatient procedures and 24 diagnoses per hospitalization.
All procedures and diagnoses are categorized by the Inter-
national Classification of Disease, 9th Clinical Modification
(ICD-9, CM) coding scheme.
In California, the PDD is linked to the California Death
Statistical Master File, the annual database of death certifi-
cates of Californians, allowing longitudinal follow-up of
inpatients after hospital discharge.7 For patients with social
security numbers, the linkage captures approximately 95%
of deaths. These include deaths occurring outside of Cali-
fornia but within the United States (US). Non-California
residents were excluded based on a county of residence
variable, as these patients cannot be followed after dis-
charge. The study was conducted with the approval of the
UCLA Institutional Review Board.
Data analysis. All patients in California undergoing
TAA repair at nonfederal institutions between 1991 and
2002 with the following codes were identified: ICD-9, CM
codes 384.4 and 384.5 (resection and replacement of ab-
dominal aorta and thoracic aorta respectively), and diag-
nostic codes 441.0 (abdominal aneurysm), 441.2 (thoracic
aneurysm), 441.4 (abdominal aortic aneurysm), 441.7
(TAA without rupture), and 441.9 (abdominal aneurysm
not otherwise specified); and rupture codes 441.1 (rup-
tured thoracic aneurysm), 441.3 (ruptured abdominal aor-
tic aneurysm), 441.5 (ruptured abdominal aneurysm not
otherwise specified), 441.6 (ruptured TAA). Patients with
additional diagnostic codes for dissections (441.03 TAA,
441.01 thoracic and 441.02 abdominal) were excluded.
The cohort of patients undergoing TAA repair was ulti-
mately identified by using these procedure and diagnosis
codes for either thoracoabdominal aneurysm repair or tho-
racic and abdominal aneurysm repair during the same op-
eration.
The inpatient file is linked to the vital statistics data,
allowing us to obtain mortality rates at 30 and 365 days for
the patients who underwent TAA repair. Data were divided
into elective and ruptured cases and stratified by patient
age. The mortality rates for TAA patients were compared
with age-matched data from the general US population
obtained from the National Vital Statistics report of 2002.8
Multivariate regression analyses were performed for
mortality at days 0 to 30, 31 to 365, and for the entire year
while controlling for age, gender, Charlson Comorbidity
Index, race, insurance type, annual volume of TAA repair
by institution (top 20%, middle and low 40%) and year of
TAA repair. The Charlson Comorbidity Index, a weighted
sum score used to risk-adjust patients, is based on presence
and severity of 19 conditions, including myocardial infarc-
tion, congestive heart failure, diabetes mellitus, and renal
disease. Values of P  .05 were considered statistically
significant. Data management was performed using SAS
version 8.01 (SAS Institute, Cary, NC), and statistical
analyses were performed using Stata 8.0 (Stata Corp, Col-
lege Station, Texas).RESULTS
A total of 1,010 patients underwent TAA repair in 166
California nonfederal hospitals from 1991 to 2002; 797
elective repairs and 213 repairs of ruptured aneurysms were
performed. The average age was 70 for elective cases and
72.1 years for ruptured cases (P  .01). Most of the
patients were white men. These data, along with Charlson
Comorbidity Index, race and ethnicity, and insurance sta-
tus are compared for elective and ruptured TAA in Table I.
For elective TAA operations, mortality was 19% at 30
days and 31% at 1 year. With ruptured TAA, mortality was
48.4% at 30 days and 61.5 % at 1 year. Mortality results
were also stratified by age in decade (Table II). For all
groups, there was continued and significant mortality for
the balance of the postoperative year. In addition, there was
increasing mortality with age. For elective patients, mortal-
ity for days 31 to 365 was 7.8% to 13.5%. Overall 1-year
mortality for these elective patients was 18.2% to 40%.
Thirty-day mortality was high after ruptured TAA, but 31-
to 365-day mortality was also substantial. One-year mor-
Table I. Patient demographics for thoracoabdominal
aneurysm repair by nonruptured vs ruptured
Elective
(n  797) (%)
Ruptured
(n  213) (%) P
Age (years) 70.0  7.1 72.1  7.6 0.01
Charlson Comorbidity
Index 2.2  1.3 2.3  1.3 .32
Race/Ethnicity .07
Non-Hispanic white 79.90 74.20
Black 5.30 8.50
Hispanic 6.00 8.90
Asian 6.30 4.20
Other 2.50 4.20
Male 61.90 67.60 .12
Insurance .78
Medicare 66.30 70.00
Medicaid 5.00 3.80
Private 26.00 23.00
Other 0.60 0.90
Indigent 2.10 2.30
Table II. Mortality rates stratified by age (%) for
thoracoabdominal aneurysm repair
Overall
50-59
years
60-69
years
70-79
years
80-89
years
Elective
Patients (n) 797 77 273 392 55
30 day (%) 19.2 10.4 17.2 21.2 27.3
31-365 (%) 11.7 7.8 9.9 13.5 12.7
365 day (%) 30.9 18.2 27.1 34.7 40.0
Ruptured
Patients (n) 213 9 63 109 32
30 day (%) 48.4 33.3 47.6 50.5 46.9
31-365 (%) 13.1 22.3 9.5 11.9 21.9
365 day (%) 61.5 55.6 57.1 62.4 68.8tality was 55.6 % for patients aged 50 to 59 and 68.8% for
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elective and ruptured TAA vs a sample of age-matched
population is shown in the figure. These death rates repre-
sent an excess mortality of three to 15 times that seen in
similar age strata in the general US population.
Volume analysis demonstrated that no hospital per-
formed an average of14 cases per year over the course of
our study. The lowest 40% was represented by institutions
performing one case per year, the middle 40% was from two
to seven cases per year, and the highest 20% of volume
ranged from seven to 14 TAA repairs per year.
Multivariate logistic regression analysis of mortality
with elective TAA repair showed associations with the
Charlson index at all time points. No other variable was
consistently associated with mortality, and it is notable that
low-volume institutions were linked to increased mortality
only with ruptured cases at the 1-year mark. These results
are summarized in Tables III, IV, and V.
DISCUSSION
This study demonstrates that the overall 1-year mortal-
ity after TAA repair in the general population is 31% for
elective and 62% for ruptured cases. Observed mortality
increased with advancing age, such that octogenarians had
mortality rates of 40% (elective) and 69% (ruptured) at
1-year. These data provide clinicians a more meaningful
method for evaluating patient risks for TAA repair than
limited perioperative mortality statistics derived from
highly specialized single institution series.
Our data, although unique in combining general pop-
ulation cases with 365-day follow-up, are consistent with
previously published reports of short-termmortality. Other
administrative database studies, using the Nationwide In-
patient Sample (NIS), have examined in-hospital mortality
with TAA repair. Cowan et al5 identified 1542 intact TAA
patients with an associated 22.3% mortality. Derrow et al6
reported on 540 intact TAA patients (over a slightly differ-
ent time period) with an inpatient mortality of 20.3%. The
state of California’s overall 30-day mortality of 19% for 797
Fig. This graph illustrates 1-year mortality for treatment of elec-
tive and ruptured thoracoabdominal aortic aneurysms (TAA). The
results are stratified into groups by increasing decade of life.
Comparison is also provided with age-matched white males. These
data are from the National Vital Statistics report.elective cases closely agrees with these numbers. Cowanet al9 also reported on ruptured TAA repair, identifying
321 patients with an in-hospital mortality of almost 54%.
Again, our overall mortality at 30 days for our 213 patients
with ruptured TAAs was 48.4%, closely approximating their
figure.
As is often the case, mortality from single center reviews
tends to be lower than that reported in the general popu-
lation. In the sentinel 1986 publication on 605 patients by
Crawford et al,10 30-day mortality was 8.9%. In the Coselli
et al11 report on 1220 patients, 30-day mortality was 4.8%.
In Gloviczki’s1 pooling of 11 major single institution TAA
studies, 4427 patients were included, with an overall 30-
day mortality of 8.7%. These data suggest the role that
hospital or surgeon volume, or patient selection, may play
in decreasing the perioperative mortality.
Previous literature concerning intermediate and late
mortality after TAA repair is all from single institutional
reviews. In the Crawford et al10 report, mortality at the
1-year mark was 21%, representing an additional 12% mor-
tality for days 31 to 365 after surgery; this is more than
double the perioperative mortality. Our day 31 to 365
mortality was 11.7% for elective cases and 13.1% for rup-
tured cases, clearly in agreement with that report. In the
Rectenwald et al12 smaller series with 101 patients, overall
1-year mortality for all cases was 33%, very close to our
combined elective/ruptured 365-day mortality rate of
37.4%. Across all of our age groups, there was continued
mortality throughout the initial postoperative year that
was higher than either age-matched populations or age-
matched patients undergoing other vascular interventions.
For example, we have previously demonstrated that the
mortality from day 31 to 365 after carotid endarterectomy
is 4.2% for patients 70 to 79 years old.13 For the same age
group undergoing TAA repair, this number increases to
13.5%, resulting in an overall mortality of 35% for that first
postoperative year.
Although we have not addressed longer-termmortality
in this report, the institutional studies that have done so
consistently find 40% to 50% of their patients have died
after 5 years.2,11,14 Longer-range assessment of TAA repair
in the general population is needed to see if the increased
30-day and 365-day mortality we observed continues be-
yond the 1-year mark.
Our findings indicate that there is increasing 30- and
365-day mortality for patients related to increasing age. In
terms of 30-day mortality in elective patients, the rate of
our youngest groups of about 10.4% differs greatly from
the 27% mortality seen in octogenarians for this period.
Some previous reports on TAA repair in the elderly have
also shown this increased mortality. The Huynh and Safi15
review of 56 octogenarians noted a 30-day mortality of
25%, and this increased to 42% at 1 year, virtually identical
with our numbers at those two time points. However,
Girardi and Coselli16 reported on 39 such patients with an
in-hospital mortality of 10.3% and concluded that this
number was not significantly different than results for pa-
tients with a mean age of 66 years.
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mortality for ruptured TAA patients. This is particularly
true in comparison with the general population, since the
yearly mortality for white men aged 79 is between 2.3% and
5.0%.11 For the ruptured TAA patients in our study, the
11-month mortality from days 31 to 365 was 13.1%. More
than half of the patients with ruptured TAA did not live 30
days, and almost two-thirds of these patients died before
the end of the first postoperative year. For the 32 octoge-
narians with a ruptured TAA, survival was just over 30% at
365 days. LeMaire et al17 found a 16% in-hospital mortality
in 112 ruptured cases. The average age of this cohort was
Table III. Multivariate logistic regression model predictin
30-day mortality
Intact (n
OR
Age (years) 1.04*
Female 1.19
Charlson Comorbidity Index 1.30*
Race
White 1.00
Black 0.79
Other 1.56
Insurance
Medicare 1.00
Medicaid 1.02
Private 0.85
Other 2.91
Annual hospital volume
High 1.00
Middle 0.65
Low 1.19
OR, Odds ratio; CI, confidence interval.
*P  .05.
Table IV. Multivariate logistic regression model predictin
31- to 365-day mortality
Intact (n 
OR
Age (years) 1.01
Female 1.40
Charlson Comorbidity Index 1.41†
Race
White 1.00
Black 0.96
Other 0.39
Insurance
Medicare 1.00
Medicaid 0.79
Private 0.61
Other 1.00
Annual hospital volume
High 1.00
Middle 0.91
Low 0.89
OR, Odds ratio; CI, confidence interval.
*The sample sizes do not include patients who died during the first 30 day
†P  .05.70, and only 3% of the patients had free rupture.17 Theyalso reported “late” mortality (30 days) of 21% for this
group. However, other authors have reported 50% to 67%
perioperative mortality for these cases.18,19 With regard to
age, the Cowan et al9 NIS data revealed a 53.8% in-hospital
mortality for ruptured TAA patients. In addition, it was
noted that age 77 years was predictive of death.
In terms of our regression analysis, comment should
be made regarding the lack of findings linked to volume.
A previous report did show an association between mor-
tality and institutions with a low volume of TAA repairs.5
That report, however, only found differences when hos-
pitals that performed 4 cases per year were compared
-day mortality
) Ruptured (n  213)
95% CI OR 95% CI
.01, 1.07) 0.99 (0.95, 1.04)
.82, 1.74) 0.85 (0.45, 1.59)
.14, 1.47) 0.74* (0.59, 0.93)
— 1.00 —
.32, 1.98) 0.34 (0.11, 1.07)
.54, 4.47) 0.69 (0.14, 3.52)
— 1.0 —
.42, 2.43) 0.70 (0.12, 4.00)
.52, 1.40) 0.37* (0.16, 0.81)
.37, 6.16) 1.16 (0.05, 26.07)
— 1.00 —
.40, 1.06) 1.31 (0.52, 3.33)
.74, 1.92) 2.48 (0.97, 6.36)
- to 365-day mortality
)* Ruptured (n  106)*
95% CI OR 95% CI
.97, 1.05) 1.05 (0.98, 1.13)
.88, 2.23) 1.29 (0.45, 3.66)
.20, 1.65) 1.36 (0.95, 1.93)
— 1.00 —
.35, 2.66) 0.33 (0.57, 1.92)
.05, 3.08) 0.56 (0.05, 6.83)
— 1.00 —
.23, 2.66) 9.85 (0.72, 134.87)
.32, 1.16) 2.07 (0.59, 7.22)
.31, 3.20) 2.18 (0.78, 6.09)
— 1.00 —
.51, 1.63) 1.79 (0.32, 9.96)
.47, 1.68) 2.14 (0.36, 12.63)g 30
 797
(1
(0
(1
(0
(0
(0
(0
(1
(0
(0g 31
627
(0
(0
(1
(0
(0
(0
(0
(0
(0
(0
s.with those that performed up to 31 cases per year. As the
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per year, it is likely that our data do not allow for a
meaningful assessment of the role of hospital volume in
TAA mortality.
The current study has some limitations. This was a
retrospective investigation that evaluated patients identi-
fied from a large state discharge database. The accuracy of
using ICD-9 codes to identify cases of TAA repairs and the
sensitivity, specificity, and accuracy of case identification in
this sample is not known. However, related major vascular
procedures such as abdominal aortic aneurysm are generally
well-coded, and there is no reason to believe that this
particular procedure should be different.20 More impor-
tantly, the current data lack clinical information that may be
important in determining outcomes. For TAA in particular,
it would be useful to determine the Crawford classification
of location and extent of TAA and the type of rupture (free
vs contained) of each case, as these factors have been shown
to influence survival.21 Furthermore, data regarding aneu-
rysm size are critical in determining the merits of operative
vs observational approaches to TAA. The current analysis
uses only a single outcome—mortality—and other out-
comes may be equally sensitive measures of clinical efficacy.
CONCLUSION
To our knowledge, this is the first study to show the
1-year mortality of TAA repair in the general population for
both elective and ruptured cases. As is usually the case,
outcomes in the general population tend to be somewhat
worse than single institutional reviews. Interestingly, those
single institution papers that comment on mortality at
1-year show continued and significant mortality beyond
the initial perioperative period. In clinical decision making,
it may be useful to consider that almost one third of patients
undergoing TAA repair in the general population will not
Table V. Multivariate logistic regression model predicting
365-day mortality
Intact (n
OR
Age (years) 1.02*
Female 1.34
Charlson Comorbidity Index 1.40*
Race
White 1.00
Black 0.84
Other 1.01
Insurance
Medicare 1.00
Medicaid 0.92
Private 0.75
Other 1.92
Annual hospital volume
High 1.00
Middle 0.75
Low 1.10
OR, Odds ratio; CI, confidence interval.
*P  .05.be alive in 1 year. When contemplating such elective repairin an octogenarian, it is probably more useful for both
surgeon and patient to consider a 365-day mortality of 40%
for this age group, reported both by Safi15 and in this
report, rather than the 10% perioperative mortality often
cited.
In addition, the natural history of TAAs is not clear;
existing data suggest repair-free survival of 24% to 52% at 2
years, although aneurysm rupture as a cause of death ranges
from 20% to 50% in these small series of patients.22,23
Further prospective data may allow for a better understand-
ing of the risks these patients face and provide more indi-
vidualized and applicable information to an individual pa-
tient when TAA repair is contemplated.
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Dr Peter Gloviczki, (Rochester, Minn). Are you convinced
that the elevated mortality beyond 30 days is really not in-hospital
procedure-related mortality?
Dr David A. Rigberg. Absolutely I can say it is not. I did not
put the data in here because it became very confusing. We have
in-hospital mortality as well. And what you find is that the numbers
are very similar to the 30-day mortality, and in fact, for some age
groups, are a little bit greater and a little bit less. This is all just
represented by patients. The numbers are still very different. It’s
about a 21% overall in-hospital mortality and you are still ending
up with 33% 1-year mortality.
Dr Richard Cambria, (Boston, Mass). Now, it appears that
California may bear some semblance to London in what is being
done with the elective surgical treatment of this extensive opera-
tion, and I think that your data will certainly inevitably be used by
payers to enforce regionalization of the care of these patients.
My question really echoed Dr Gloviczki’s about how you
stratify. Where did you get this 30-day mortality figure from if you
are looking at discharge data? Because many of these patients,
particularly the complicated ones, will go on with 2- or 3-month
hospitalizations, and the so-called in-hospital versus 30-day mor-
tality may be the better way to look at it.
Dr Rigberg. We have available to us mortality at many time
points—at 30 days, at 60 days, and essentially throughout that first
postoperative year and beyond if we wished. We decided to use the
30-day versus the in-hospital mortality because we could say for
every patient where that cutoff was. Whereas with the in-hospital,the in-hospital data essentially were not distinct from the year-end
data, then these studies would not have a lot of relevance.
But what we found is that is not the case. That essentially
whether you look at in-hospital data or whether you look at 30-day
data, there is continued and significant mortality beyond that time
point.
We have included the 30-day data because it is a defined time
point where you don’t wonder how long that patient was in the
hospital before dying.
Dr Michael Jacobs, (Maastricht, The Netherlands). I would
like to ask you, if you would break down your results to the type II
aneurysms, I guess the mortality rate would be even much higher.
I also would like to support your third conclusion with regard
to centralization of this kind of surgery, because obviously, it is not
only this surgical trick, but more the intraoperative interaction
between the anesthesiologist, the perfusionist, and the surgeon,
and especially after surgery in the intensive care. And if you do this
procedure once a year, this team can obviously not offer the
optimal treatment like they should. So I fully support the idea, not
only in the United States but also all over the world, to centralize
these kinds of procedures.
Dr Rigberg. I would just add that if you look at even the
highly specialized institutional series, going back to Dr Crawford’s
series in 1986, with less than 10% in-hospital mortality, even in that
study, by the end of the year there is an additional 10% or 11%
mortality for the patients that are making it out of the hospital. So
I do think it is a real phenomenon that you can see in probably any
study that you look at carefully enough.
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Rigberg et al have documented that the 30-day mortality rate
for elective thoracoabdominal aortic aneurysm (TAA) repair in
California from 1991 to 2002 was a sobering 19%. Furthermore,
an additional 12% of the patients died between 31 and 365 days,
for an overall 365-day mortality rate of 31%. Notably, this added
mortality for elective repair during the first year was not due to
in-hospital deaths not accounted for in the initial 30-day rate (see
Discussion following text). The elective mortality rate increased by
age group, with 30-day and 365-day rates in the oldest group (80
to 89 years) of 27% and 40%, respectively. Predictably, the mortal-
ity rates for the ruptured repair were significantly greater both
overall and per the different age groups. The authors’ findings are
consistent with several other nationwide reports documenting the
perioperativemortality after TAA repair, but contrast with the single-
institution reports from centers of excellence that have consistently
reported perioperative mortality rates of 10%.
Despite the limitations of the study (ie, retrospective design,
administrative database, limited clinical data, lack of control), the
poor results mandate re-evaluation of the clinical care delivery
system for patients with TAAs. First, the indications for operative
repair and the natural history of untreated TAAs likely need to be
further defined. The common recommendations for operative
repair range from a diameter of 5.5 to 6.5 cm, with Elefteriades1
reporting an annual combined rupture/dissection/mortality rate
of 14% for thoracic aortic aneurysms.
It is important, however, to remember that the elective repair
of a TAA is a prophylactic operation that is indicated when the risk
of rupture exceeds the risk of expectant or nonoperative manage-
ment. Although the size and extent of the aneurysms was not
available in the current study, it is unlikely that the annual rupture
risk exceeded the reported 365-day mortality rates, particularly for
the oldest subset of patients. Additionally, mortality was the onlyoutcome measure analyzed; but the associated risk of respiratory
failure, paraplegia, and renal failure are significant. Incorporation
of these additional adverse outcome measures into the analysis
would likely further undermine the role of TAA repair.
Second, the operative procedures should likely be concen-
trated in true “centers of excellence.” Hospital and provider pro-
cedural volumes have been related with outcome for almost every
major surgical procedure, and TAA repair is no exception. Indeed,
an experienced clinical delivery system for TAA repair is essential
given the complexity of the procedure from a surgical, anesthetic,
and critical care standpoint. It was surprising that 40% of the
procedures were performed at institutions that averaged a single
TAA repair per year, and no institution averaged more than 14
procedure per year.
Finally, alternative approaches for the repair of TAA should be
pursued. Black et al2 have recently documented their initial expe-
rience with a hybrid visceral revascularization and stent-graft repair
for TAA with an elective perioperative mortality of 18% and no
paraplegia. Furthermore, the worldwide experience with branch
endografts for TAA and suprarenal aneurysms is expanding rapidly,
and it may be possible to safely and effectively treat aneurysms
throughout the whole length of the aorta within a few years.
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